ArticleAnnals of the rheumatic diseases2023

Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis.

Samantha Louise Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.